S. 4717

S. 4717: A bill to amend the Public Health Service Act to require the Director of the National Institutes of Health to develop a national strategy to address young adult cancers, and for other purposes.

Introduced Edward Markey (D) SENATE_BILL — 119th Congress
Plain English Summary

S. 4717 is a bill that aims to amend the Public Health Service Act by requiring the Director of the National Institutes of Health (NIH) to create a national strategy specifically focused on addressing cancers that affect young adults. This includes developing research initiatives, funding opportunities, and public health campaigns to improve outcomes for this demographic.

Positive Media Summary

Supporters of S. 4717 have praised the bill for its focus on a critical and often overlooked demographic in cancer research. Media outlets have highlighted the importance of addressing young adult cancers, which tend to receive less attention and funding compared to pediatric and older adult cancers. Advocates believe this bill could lead to significant advancements in treatment and support for young adults battling cancer.

Negative Media Summary

Critics of S. 4717 have expressed concerns about the bill's potential for bureaucratic inefficiency and the allocation of resources. Some media reports suggest that while the intention is noble, the bill may not adequately address the underlying issues of funding and research prioritization in the broader context of cancer treatment. Additionally, there are worries that the focus on young adult cancers could divert attention from other pressing health issues.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The analysis of Bill S. 4717, which aims to address young adult cancers, reveals no direct industry overlaps between the sponsor Edward Markey's top donor industries and the bill's subject matter. This indicates a low risk of conflicts of interest arising from the financial contributions to the sponsor. The lobbying activity related to this bill includes various organizations, such as SASOL CHEMICALS USA LLC, which contributed $260,000, but their interests do not appear to align with the health-focused objectives of the bill. The absence of direct financial ties suggests that the motivations behind the bill are likely to be driven by public health concerns rather than donor interests.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
SASOL CHEMICALS USA LLC SASOL CHEMICALS USA LLC $260,000
ENERGY INFRASTRUCTURE COUNCIL FKA MASTER LIMITED PARTNERSHIP ASSOCIATION ZIEBART CONSULTING, LLC $60,000
ORGANIC PRODUCE ASSOCIATION THE RUSSELL GROUP, INC. $50,000
GRAVITICS TECHNOLOGY STRATEGIES LLC $30,000
LIVINGSTON INTERNATIONAL INC VENABLE LLP $30,000
CITY OF WILLISTON (ND) NEXXUS CONSULTING, LLC $30,000
NATIONAL ASSOCIATION OF POSTAL SUPERVISORS NATIONAL ASSOCIATION OF POSTAL SUPERVISORS $28,000
S&P GLOBAL F/K/A IHS MARITIME & TRADE VENABLE LLP $20,000
TOWN OF TUSAYAN NEXXUS CONSULTING, LLC $10,000
TREA SENIOR CITIZENS LEAGUE TREA SENIOR CITIZENS LEAGUE $5,000
NATIONAL RELIGIOUS BROADCASTERS NATIONAL RELIGIOUS BROADCASTERS undisclosed
INTERNATIONAL REGISTRIES, INC. VENABLE LLP undisclosed
ARISTEIA STRATEGIC ADVISORS, LLC ARISTEIA STRATEGIC ADVISORS, LLC undisclosed
US CHEMICAL TECHNOLOGIES ATS COMMUNICATIONS, INC. (DBA SILBEY STRATEGIES) undisclosed
CX2 ATS COMMUNICATIONS, INC. (DBA SILBEY STRATEGIES) undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Edward Markey, ranked by total contributions.

Health Professionals $480,000,000
Individuals: $480,000,000 PACs: $0
Retired $150,000,000
Individuals: $150,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us